---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-286737"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2026-06-29T10:03:19+00:00"
generated_at: "2026-06-29T10:05:11.767626+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Decoy Therapeutics raises $3.5M upfront in PIPE, up to $21M with milestone warrants

## Summary
- Gross proceeds of $3.5M from sale of 592,217 shares (or pre-funded warrants) at $5.91/share.
- Milestone warrants could add $3.5M (Series A), $7.0M (Series B), and $7.0M (Series C) if triggered.
- Proceeds to advance lead asset into clinical trials; closing expected June 29, 2026.
- Executives and directors subject to 90-day lock-up; Curvature Securities acting as placement agent.
- Registration rights agreement requires filing resale registration statement within 15 calendar days.

## SEC filing metadata
- accession: 0001193125-26-286737
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2026-06-29T10:03:19+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/0001193125-26-286737-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/dcoy-20260626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-286737
- JSON: https://secwatch.observer/filing/0001193125-26-286737.json
- Plain text: https://secwatch.observer/filing/0001193125-26-286737.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.